Reminder - Cypress Energy Partners (CELP) Goes Ex-Dividend Soon

Looking at the universe of stocks we cover at Dividend Channel, on 11/3/16, Cypress Energy Partners LP (CELP) will trade ex-dividend, for its quarterly dividend of $0.4064, payable on 11/14/16. As a percentage of CELP's recent stock price of $10.23, this dividend works out to approximately 3.97%, so look for shares of Cypress Energy Partners LP to trade 3.97% lower — all else being equal — when CELP shares open for trading on 11/3/16.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for CELP, showing historical dividends prior to the most recent $0.4064 declared by Cypress Energy Partners LP:

CELP+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from CELP is likely to continue, and whether the current estimated yield of 15.89% on annualized basis is a reasonable expectation of annual yield going forward. The chart below shows the one year performance of CELP shares, versus its 200 day moving average:

Cypress Energy Partners LP 200 Day Moving Average Chart

Looking at the chart above, CELP's low point in its 52 week range is $5.28 per share, with $12.36 as the 52 week high point — that compares with a last trade of $10.23.

In Tuesday trading, Cypress Energy Partners LP shares are currently off about 1.2% on the day.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says